BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37216595)

  • 1. CRISPRimmunity: an interactive web server for CRISPR-associated Important Molecular events and Modulators Used in geNome edIting Tool identifYing.
    Zhou F; Yu X; Gan R; Ren K; Chen C; Ren C; Cui M; Liu Y; Gao Y; Wang S; Yin M; Huang T; Huang Z; Zhang F
    Nucleic Acids Res; 2023 Jul; 51(W1):W93-W107. PubMed ID: 37216595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine-learning approach expands the repertoire of anti-CRISPR protein families.
    Gussow AB; Park AE; Borges AL; Shmakov SA; Makarova KS; Wolf YI; Bondy-Denomy J; Koonin EV
    Nat Commun; 2020 Jul; 11(1):3784. PubMed ID: 32728052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome mining for anti-CRISPR operons using machine learning.
    Yang B; Khatri M; Zheng J; Deogun J; Yin Y
    Bioinformatics; 2023 May; 39(5):. PubMed ID: 37158576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity and evolution of class 2 CRISPR-Cas systems.
    Shmakov S; Smargon A; Scott D; Cox D; Pyzocha N; Yan W; Abudayyeh OO; Gootenberg JS; Makarova KS; Wolf YI; Severinov K; Zhang F; Koonin EV
    Nat Rev Microbiol; 2017 Mar; 15(3):169-182. PubMed ID: 28111461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AcaFinder: Genome Mining for Anti-CRISPR-Associated Genes.
    Yang B; Zheng J; Yin Y
    mSystems; 2022 Dec; 7(6):e0081722. PubMed ID: 36413017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and applications of Type I CRISPR-Cas systems.
    Hidalgo-Cantabrana C; Barrangou R
    Biochem Soc Trans; 2020 Feb; 48(1):15-23. PubMed ID: 31922192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in the RNA-targeting CRISPR-Cas systems].
    Hong T; Luo Q
    Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1363-1373. PubMed ID: 37154311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PreAcrs: a machine learning framework for identifying anti-CRISPR proteins.
    Zhu L; Wang X; Li F; Song J
    BMC Bioinformatics; 2022 Oct; 23(1):444. PubMed ID: 36284264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics Identification of Anti-CRISPR Loci by Using Homology, Guilt-by-Association, and CRISPR Self-Targeting Spacer Approaches.
    Yin Y; Yang B; Entwistle S
    mSystems; 2019 Sep; 4(5):. PubMed ID: 31506266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPRedict: a CRISPR-Cas9 web tool for interpretable efficiency predictions.
    Konstantakos V; Nentidis A; Krithara A; Paliouras G
    Nucleic Acids Res; 2022 Jul; 50(W1):W191-W198. PubMed ID: 35670672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-GRANT: a cross-platform graphical analysis tool for high-throughput CRISPR-based genome editing evaluation.
    Fu H; Shan C; Kang F; Yu L; Li Z; Yin Y
    BMC Bioinformatics; 2023 May; 24(1):219. PubMed ID: 37254060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Approaches for Prediction of Anti-CRISPR Proteins.
    Makarova KS; Wolf YI; Koonin EV
    J Mol Biol; 2023 Apr; 435(7):168036. PubMed ID: 36868398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AcrPred: A hybrid optimization with enumerated machine learning algorithm to predict Anti-CRISPR proteins.
    Dao FY; Liu ML; Su W; Lv H; Zhang ZY; Lin H; Liu L
    Int J Biol Macromol; 2023 Feb; 228():706-714. PubMed ID: 36584777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CasPDB: an integrated and annotated database for Cas proteins from bacteria and archaea.
    Tang Z; Chen S; Chen A; He B; Zhou Y; Chai G; Guo F; Huang J
    Database (Oxford); 2019 Jan; 2019():. PubMed ID: 31411686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPRCasStack: a stacking strategy-based ensemble learning framework for accurate identification of Cas proteins.
    Zhang T; Jia Y; Li H; Xu D; Zhou J; Wang G
    Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 35998924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas: from adaptive immune system in prokaryotes to therapeutic weapon against immune-related diseases.
    Garcia-Robledo JE; Barrera MC; Tobón GJ
    Int Rev Immunol; 2020; 39(1):11-20. PubMed ID: 31625429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A decade of discovery: CRISPR functions and applications.
    Barrangou R; Horvath P
    Nat Microbiol; 2017 Jun; 2():17092. PubMed ID: 28581505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
    Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPRloci: comprehensive and accurate annotation of CRISPR-Cas systems.
    Alkhnbashi OS; Mitrofanov A; Bonidia R; Raden M; Tran VD; Eggenhofer F; Shah SA; Öztürk E; Padilha VA; Sanches DS; de Carvalho ACPLF; Backofen R
    Nucleic Acids Res; 2021 Jul; 49(W1):W125-W130. PubMed ID: 34133710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting endogenous CRISPR-Cas system for multiplex genome editing in Clostridium tyrobutyricum and engineer the strain for high-level butanol production.
    Zhang J; Zong W; Hong W; Zhang ZT; Wang Y
    Metab Eng; 2018 May; 47():49-59. PubMed ID: 29530750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.